Literature DB >> 33147733

Case Series of Dengue Fever in Peripartum Period: Maternal and Foetal Outcome.

Yudianto Budi Saroyo1, Ali Sungkar1, Rima Irwinda1, Raymond Surya1.   

Abstract

Introduction: Dengue fever is a major public health problem in tropical and subtropical areas. There are not many studies concerning the complications of dengue fever in pregnancy. We present four serial cases of dengue fever in pregnancy. Case illustration: Three of four cases were delivered by caesarean section; two of them died during post-caesarean care. All cases had the lowest platelet level below 50,000/µL and were given platelet transfusion during and after delivery; they also showed abnormal liver function tests. For foetal outcome, none tested positive for dengue. Discussion: Complication of dengue infection depends on a combination of host and viral virulence. Regardless of prophylactic platelet transfusion, some studies revealed clinical bleeding in patients with dengue infection due to an intricate effect on the haemostatic system. The adverse foetal outcome may contribute because of placental circulation caused by endothelial damage with increased vascular permeability leading to plasma leakage. There is no national guideline for dengue fever in pregnancy. Conclusions: The management of dengue fever in pregnancy at the tertiary hospital is still suboptimal. Dengue fever around peripartum presents a higher risk of morbidity and mortality for the mother and therefore needs a multidiscipline team approach.

Entities:  

Keywords:  dengue fever; foetal outcome; maternal outcome; pregnancy

Year:  2020        PMID: 33147733      PMCID: PMC7768497          DOI: 10.3390/idr12030013

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN: 2036-7430


  16 in total

1.  DENGUE INFECTION IN PREGNANCY.

Authors:  Kriangsak Khamim; Boonluck Khamim; Krisana Pengsaa
Journal:  Southeast Asian J Trop Med Public Health       Date:  2015       Impact factor: 0.267

2.  Haemostatic reference intervals in pregnancy.

Authors:  Pal B Szecsi; Maja Jørgensen; Anna Klajnbard; Malene R Andersen; Nina P Colov; Steen Stender
Journal:  Thromb Haemost       Date:  2010-02-19       Impact factor: 5.249

3.  Maternal and fetal consequences of dengue fever during pregnancy.

Authors:  Célia Basurko; Gabriel Carles; Mohamed Youssef; Wael E L Guindi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-07-24       Impact factor: 2.435

4.  Dengue infection in pregnancy: prevalence, vertical transmission, and pregnancy outcome.

Authors:  Peng Chiong Tan; Geetha Rajasingam; Shamala Devi; Siti Zawiah Omar
Journal:  Obstet Gynecol       Date:  2008-05       Impact factor: 7.661

Review 5.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 6.  Arboviruses and pregnancy: maternal, fetal, and neonatal effects.

Authors:  Caroline Charlier; Marie-Claude Beaudoin; Thérèse Couderc; Olivier Lortholary; Marc Lecuit
Journal:  Lancet Child Adolesc Health       Date:  2017-08-10

Review 7.  Transfusion support in patients with dengue fever.

Authors:  Paramjit Kaur; Gagandeep Kaur
Journal:  Int J Appl Basic Med Res       Date:  2014-09

8.  The changing incidence of dengue haemorrhagic fever in Indonesia: a 45-year registry-based analysis.

Authors:  Mulya Rahma Karyanti; Cuno S P M Uiterwaal; Rita Kusriastuti; Sri Rezeki Hadinegoro; Maroeska M Rovers; Hans Heesterbeek; Arno W Hoes; Patricia Bruijning-Verhagen
Journal:  BMC Infect Dis       Date:  2014-07-26       Impact factor: 3.090

9.  Case Report: Postpartum hemorrhage associated with Dengue with warning signs in a term pregnancy and delivery.

Authors:  Le Phi Hung; Tran Diem Nghi; Nguyen Hoang Anh; Mai Van Hieu; Nguyen Thien Luan; Nguyen Phuoc Long; Than Trong Thach
Journal:  F1000Res       Date:  2015-12-21

Review 10.  Physiologic and pharmacokinetic changes in pregnancy.

Authors:  Maged M Costantine
Journal:  Front Pharmacol       Date:  2014-04-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.